Becton Dickinson and Company (BDX): $1.39 million was the positive money flow into the stock on Tuesday and the up/down ratio of ticks was also in favor of the bulls at 1.06. The value of trades done on upticks was $24.3 million, whereas, trades done on downticks were valued at $22.91 million. Money flows are calculated as the dollar value of composite uptick trades minus the dollar value of downtick trades. large traders, also sometimes called as the smart money, block traded $2.05 million worth stocks on upticks, which is a bullish indication. The money flow in block trades was $2.05 million. Becton Dickinson and Company (BDX) fell $0.19 traded at $176.16, a change of -0.11% over the previous day. The stock is 0.3% for the week.
The company Insiders own 1.6% of Becton Dickinson and Company shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -21.24% . Institutional Investors own 85.46% of Becton Dickinson and Company shares. During last six month period, the net percent change held by insiders has seen a change of -21.24%. In an insider trading activity, Gallagher John E, officer (VP, Corp Finance and Treasurer) of Becton Dickinson & Co, unloaded 1,931 shares at an average price of $169.87 on June 13, 2016. The total amount of the transaction was worth $328,019, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Shares of Becton, Dickinson and Company rose by 2.62% in the last five trading days and 3.79% for the last 4 weeks. Becton, Dickinson and Company is up 11.87% in the last 3-month period. Year-to-Date the stock performance stands at 14.98%.
Becton Dickinson and Company (NYSE:BDX): On Tuesdays trading session , Opening price of the stock was $176.46 with an intraday high of $176.91. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $175.61. However, the stock managed to close at $175.7, a loss of 0.37% for the day. On the previous day, the stock had closed at $176.35. The total traded volume of the day was 843,642 shares.
Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Companys Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Companys BD Medical segment focuses on providing solutions to reduce the spread of infection, enhance diabetes treatment and advance drug delivery. The Companys BD Diagnostics provides products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians.